The global cartilage repair market was valued at USD 5.34 billion in 2024 and is projected to grow from USD 5.60 billion in 2025 to USD 8.23 billion by 2032, registering a compound annual growth rate (CAGR) of 5.65% during the forecast period.
Cartilage is a flexible connective tissue that cushions the ends of bones and supports smooth joint movement. Unlike many other tissues, cartilage has a limited ability to heal naturally because it receives little direct blood supply. Injuries, aging, and degenerative conditions can therefore cause lasting damage, resulting in pain, stiffness, and reduced mobility.
Cartilage repair treatments aim to restore damaged joint surfaces, relieve symptoms, and preserve joint function. The market includes cell-based therapies, biomaterials, synthetic implants, tissue-engineered scaffolds, surgical procedures, and related treatment solutions.
Demand is increasing as more people experience osteoarthritis, sports-related injuries, and other joint disorders. At the same time, advancements in regenerative medicine and minimally invasive surgery are expanding treatment options for patients who want to preserve their natural joints and potentially delay joint replacement.
According to Kings Research, North America accounted for 40.11% of the global market in 2024, while Asia Pacific is expected to record the fastest regional growth during the forecast period.
Key Trends Shaping the Cartilage Repair Market
1. Increasing Adoption of Minimally Invasive Procedures
Minimally invasive procedures are becoming increasingly important in cartilage repair. Techniques such as arthroscopy allow surgeons to examine and treat joint damage through small incisions, reducing disruption to surrounding tissues.
These procedures can help patients experience shorter hospital stays, less surgical trauma, and faster rehabilitation compared with more invasive approaches. Healthcare providers are also exploring hydrogel implants and one-step repair technologies to improve treatment efficiency.
In April 2025, Hy2Care received FDA investigational device exemption approval to begin its first U.S. clinical trial for the CartRevive hydrogel implant. The technology is designed to address traumatic knee cartilage injuries through a minimally invasive treatment approach.
kingsresearch.com
2. Growth of Cell-Based and Regenerative Therapies
Regenerative medicine is creating new opportunities for cartilage repair. Cell-based therapies use living cells to support the restoration of damaged cartilage, while tissue engineering combines cells, biomaterials, and specialized structures to encourage tissue development.
Autologous chondrocyte implantation is one example. It involves collecting a patient’s cartilage cells, growing them in a controlled environment, and implanting them into the damaged area.
Researchers are also developing advanced scaffolds and bioactive materials that provide a supportive environment for cartilage cells. These technologies could improve tissue integration and expand treatment options for patients with significant cartilage damage.
3. Rising Interest in Advanced Biomaterials
Biomaterials play an important role in modern cartilage repair procedures. Synthetic implants, collagen-based materials, hydrogels, and tissue-engineered scaffolds can provide structural support to damaged areas.
Research institutions and medical technology companies are working to develop materials that more closely resemble natural cartilage. Such innovations may improve the stability, durability, and integration of repaired tissue.
In March 2025, Drexel University received an NSF research grant to advance RibbonGel, a material designed to create a stable three-dimensional environment for cartilage cells and support healing and joint integration.
kingsresearch.com
Key Growth Drivers of the Cartilage Repair Market
1. Rising Incidence of Sports and Recreational Injuries
Growing participation in sports, fitness activities, and recreational exercise is increasing the number of people exposed to joint injuries. Activities involving running, jumping, sudden direction changes, and physical contact can place considerable pressure on the knee, hip, and ankle joints.
Cartilage damage may occur following traumatic injuries or repeated stress. When untreated, it can contribute to persistent discomfort and long-term joint problems.
The National Safety Council reported that sports and recreational injuries increased by 17% in 2024, reaching 564,845 cases compared with 482,886 in 2023. This growing injury burden is supporting demand for cartilage repair treatments.
kingsresearch.com
2. Increasing Prevalence of Osteoarthritis
Osteoarthritis is a major contributor to cartilage damage, particularly among older adults. The condition involves the gradual breakdown of joint cartilage, which can lead to pain, swelling, stiffness, and difficulty performing everyday activities.
As populations age, the number of individuals requiring treatment for degenerative joint conditions is expected to increase. Patients and healthcare providers are increasingly considering treatment options that preserve joint function and help delay more extensive procedures.
This is encouraging the development and adoption of cartilage restoration technologies, including biomaterials, cell-based therapies, and minimally invasive surgical solutions.
3. Technological Advancements in Orthopedic Treatments
Advances in medical devices, imaging, surgical instruments, and regenerative medicine are improving the range of available cartilage repair procedures.
New technologies are helping surgeons identify cartilage defects more accurately and select appropriate treatments based on injury severity and patient needs. Improved biomaterials and implant designs are also supporting the development of procedures intended to restore joint surfaces.
Investment in research and development is likely to remain an important factor in introducing new products and expanding treatment options.
4. Growing Demand for Joint Preservation
Many patients seek treatment options that maintain their natural joints for as long as possible. Joint replacement may be appropriate for severe conditions, but cartilage repair can offer an alternative for selected patients with localized damage.
This demand is encouraging healthcare providers to consider treatments that address cartilage defects before they progress into more extensive joint deterioration.
Market Challenges
High Cost of Advanced Cartilage Repair Procedures
The high cost of advanced treatment is a major challenge for the cartilage repair market. Cell-based therapies, tissue-engineered scaffolds, and hydrogel implants can require specialized facilities, skilled medical professionals, laboratory processing, and advanced surgical equipment.
Patients may also face additional expenses associated with rehabilitation, follow-up appointments, and post-operative monitoring. These costs can restrict access, particularly in healthcare systems where reimbursement coverage is limited.
To address this challenge, manufacturers are working on scalable production methods, streamlined procedures, and cost-efficient biomaterials. Greater collaboration with hospitals, insurers, and healthcare providers may also help improve affordability and access.
Complex Regulatory and Clinical Approval Requirements
Cartilage repair products often involve advanced medical devices, biological materials, or cell-based technologies. These products must meet regulatory requirements related to safety, quality, and clinical effectiveness.
Companies may need to conduct extensive testing and clinical trials before receiving approval to commercialize new products. This can increase development costs and extend the time required to introduce innovations.
Cartilage Repair Market Segmentation Analysis
The global market is segmented by treatment modality, treatment procedure, application, end-user, and region.
By Treatment Modality
Based on treatment modality, the market is divided into:
-
Cell-Based Therapies: These treatments use living cells to support cartilage regeneration. They are an important area of regenerative medicine and are being developed for patients with specific cartilage defects.
-
Non-Cell-Based Therapies: These include synthetic implants, biomaterials, scaffolds, and other solutions that support cartilage repair without directly relying on implanted living cells.
The non-cell-based therapies segment generated USD 3.45 billion in 2024, supported by the widespread adoption of synthetic implants and biomaterials. It is projected to remain a significant part of the market, with revenue expected to reach USD 5.19 billion by 2032.
kingsresearch.com
By Treatment Procedure
The market is categorized into:
-
Palliative: Palliative procedures focus on reducing pain and improving joint function. This approach is relevant for patients who require symptom relief or may not be suitable candidates for certain advanced surgical treatments.
-
Intrinsic Repair Stimulus: These procedures aim to stimulate the body’s natural healing response and encourage the formation of repair tissue.
The palliative segment held a 57.32% share in 2024. Its position reflects the continued demand for symptom management among patients with degenerative joint conditions.
kingsresearch.com
By Application
Based on application, the market includes:
-
Knee: Knee cartilage damage is associated with sports injuries, osteoarthritis, and other joint conditions. The knee segment is projected to reach USD 4.71 billion by 2032.
-
Hip: Hip cartilage repair addresses damage that can affect mobility and daily activities. This segment is expected to register the fastest CAGR of 6.69% during the forecast period.
-
Ankle & Foot: Treatments in this category address cartilage injuries and defects affecting the ankle and foot joints.
-
Others: This category includes other applications requiring cartilage restoration solutions.
kingsresearch.com
By End-User
The market is divided into:
-
Hospitals & Clinics: These facilities provide diagnosis, surgical procedures, specialized orthopedic care, and post-treatment rehabilitation. Hospitals and clinics accounted for 55.43% of the market in 2024.
-
Ambulatory Surgical Centers: These centers provide selected surgical procedures in outpatient settings. The segment is expected to grow at a CAGR of 6.55%, supported by increasing preference for outpatient and minimally invasive treatments.
kingsresearch.com
Regional Analysis of the Cartilage Repair Market
The cartilage repair market is analyzed across North America, Europe, Asia Pacific, the Middle East & Africa, and South America.
North America
North America dominated the global cartilage repair market in 2024, accounting for 40.11% of the market and generating USD 2.14 billion in revenue. The region benefits from advanced healthcare infrastructure, established orthopedic treatment facilities, and the availability of innovative medical technologies.
The increasing prevalence of osteoarthritis and sports-related joint injuries is supporting demand for cartilage restoration procedures. Strong research and development activity, along with the presence of established medical device companies, is also contributing to regional growth.
In August 2024, Vericel launched MACI Arthro following FDA approval of a supplemental Biologics License Application. The product is designed for arthroscopic delivery of cultured cartilage cells to treat full-thickness knee cartilage defects.
kingsresearch.com
Europe
Europe represents an important market due to its established healthcare systems, growing elderly population, and increasing focus on orthopedic care. Countries such as Germany, the United Kingdom, France, Italy, and Spain are important markets for advanced cartilage repair procedures.
Investment in regenerative medicine, clinical research, and medical technology development is supporting innovation across the region. Increasing awareness of joint preservation and minimally invasive treatment options is also creating opportunities for manufacturers.
However, reimbursement policies and differences in healthcare spending across countries may influence the adoption of advanced cartilage repair therapies.
Asia Pacific
Asia Pacific is expected to be the fastest-growing regional market, registering a CAGR of 6.49% during the forecast period. Growth is supported by the expanding elderly population, increasing prevalence of osteoarthritis, and rising incidence of sports-related injuries in countries such as China and India.
Japan and South Korea are also investing in regenerative medicine research and advanced cartilage treatment technologies. Improvements in healthcare infrastructure and increasing access to specialized orthopedic services are expected to support market expansion.
In May 2025, Japan Tissue Engineering Co., Ltd. received approval to expand the indication of its autologous cultured cartilage product, JACC, for treating osteoarthritis and knee cartilage damage.
kingsresearch.com
Middle East & Africa
The Middle East & Africa market is developing as healthcare infrastructure improves and governments increase investments in specialized medical services. Growing awareness of orthopedic conditions and access to advanced surgical procedures are supporting demand.
Countries such as the United Arab Emirates, Saudi Arabia, Turkey, and South Africa are important markets for healthcare technology adoption. However, limited access to specialized facilities and the high cost of advanced treatments may restrict wider adoption.
South America
South America is expected to experience gradual growth, supported by improvements in healthcare services and increasing demand for orthopedic treatments. Brazil and Argentina represent important markets due to their healthcare infrastructure and growing focus on joint-related conditions.
The adoption of advanced cartilage repair procedures may increase as medical facilities expand their capabilities and patients gain greater access to specialized treatment options.
Competitive Landscape of the Cartilage Repair Market
The cartilage repair market includes established medical device manufacturers, biotechnology companies, and regenerative medicine specialists. Market participants are focusing on product innovation, research collaborations, clinical development, and strategic acquisitions to strengthen their competitive positions.
Companies are investing in cell-based therapies, biomaterials, tissue-engineered implants, and minimally invasive surgical solutions. They are also working to improve product availability and expand their presence across regional markets.
Key companies operating in the market include:
-
Vericel Corporation
-
Zimmer Biomet Holdings, Inc.
-
Smith+Nephew
-
Arthrex, Inc.
-
Stryker Corporation
-
B. Braun SE
-
CONMED Corporation
-
Anika Therapeutics, Inc.
-
MEDIPOST Co., Ltd.
-
Geistlich Pharma AG
-
Orthocell Ltd.
-
AlloSource
-
Collagen Solutions Ltd.
-
Sparta Biomedical Inc.
-
TissueForm, Inc.
Recent Industry Developments
-
June 2025: OrthoCellix and Carisma Therapeutics entered into a definitive merger agreement to form a company focused on regenerative cell therapies for orthopedic diseases. The agreement aims to advance NeoCart, an autologous cartilage implant technology developed for knee cartilage defects.
-
January 2024: Smith+Nephew acquired CartiHeal to gain access to Agili-C, a one-step cartilage repair technology designed to treat osteochondral lesions in the knee, including cases involving mild to moderate osteoarthritis.
-
August 2024: Northwestern University developed a bioactive material designed to mimic natural cartilage and support cartilage repair, with potential applications in sports injuries and degenerative joint conditions.
kingsresearch.com
Future Opportunities in the Cartilage Repair Market
The future of the cartilage repair market will be shaped by continued research into regenerative medicine, advanced biomaterials, and personalized orthopedic treatments.
Expansion of Regenerative Medicine: Improvements in cell-based therapies and tissue engineering may create new treatment possibilities for patients with complex cartilage defects. Research into materials that support cell growth and tissue integration could improve the effectiveness of future procedures.
Development of Next-Generation Implants: Manufacturers have opportunities to develop implants that better replicate the structure and mechanical properties of natural cartilage. Advanced hydrogels, collagen-based scaffolds, and bioactive materials may support more effective cartilage restoration.
Growing Opportunities in Emerging Economies: Increasing healthcare investment in India, China, and other emerging economies may improve access to specialized orthopedic procedures. Partnerships with hospitals and regional healthcare providers can help manufacturers expand their market presence.
Growth of Outpatient Procedures: The increasing preference for minimally invasive treatments and outpatient care creates opportunities for ambulatory surgical centers. Technologies that reduce procedure complexity and recovery time may support this shift.
Greater Investment in Clinical Research: Clinical studies and long-term patient outcome assessments will remain important for demonstrating the safety and effectiveness of new cartilage repair technologies. Companies that establish strong clinical evidence may improve product adoption and regulatory acceptance.
Conclusion
The global cartilage repair market is expected to experience steady growth through 2032, supported by the rising prevalence of osteoarthritis, increasing sports-related injuries, and growing demand for joint-preserving treatments. The market is projected to increase from USD 5.34 billion in 2024 to USD 8.23 billion by 2032, registering a CAGR of 5.65%.
Technological advancements in cell-based therapies, biomaterials, tissue engineering, and minimally invasive procedures are creating new opportunities for healthcare providers and medical technology companies. While high treatment costs and regulatory requirements remain important challenges, ongoing research and product innovation are expected to strengthen the industry’s development.
As healthcare systems increasingly focus on mobility, quality of life, and effective orthopedic care, cartilage repair technologies are likely to play an important role in the future of joint treatment and regenerative medicine.
